Showing results (11-20 of 34) with videos related to
Sort By:
Pageof 4
Cancer Research|August 3, 2007
Novel tryptophan catabolic enzyme IDO2 is the preferred biochemical target of the antitumor indoleamine 2,3-dioxygenase inhibitory compound D-1-methyl-tryptophanRichard Metz, James B Duhadaway, Uma Kamasani, et al.Immunological Reviews|August 15, 2012
Amino acid catabolism: a pivotal regulator of innate and adaptive immunityTracy L McGaha, Lei Huang, Henrique Lemos, et al.Molecular Endocrinology (Baltimore, Md.)|November 17, 2007
Vascular endothelial growth factor receptor-2 expression is down-regulated by 17beta-estradiol in MCF-7 breast cancer cells by estrogen receptor alpha/Sp proteinsKelly J Higgins, Shengxi Liu, Maen Abdelrahim, et al.Cancer Immunology, Immunotherapy : CII|April 9, 2014
Indoleamine 2,3-dioxygenase pathways of pathogenic inflammation and immune escape in cancerGeorge C Prendergast, Courtney Smith, Sunil Thomas, et al.Molecular Cancer Therapeutics|June 10, 2010
Zinc protoporphyrin IX stimulates tumor immunity by disrupting the immunosuppressive enzyme indoleamine 2,3-dioxygenaseRichard Metz, James B Duhadaway, Sonja Rust, et al.Journal of Immunology (Baltimore, Md. : 1950)|February 4, 2014
IDO2 is a critical mediator of autoantibody production and inflammatory pathogenesis in a mouse model of autoimmune arthritisLauren M F Merlo, Elizabeth Pigott, James B DuHadaway, et al.G3 (Bethesda, Md.)|November 9, 2021
Genetic and genomic architecture in eight strains of the laboratory opossum Monodelphis domesticaXiao Xiong, Paul B Samollow, Wenqi Cao, et al.Journal of the American College of Surgeons|May 30, 2009
Genotyping and expression analysis of IDO2 in human pancreatic cancer: a novel, active targetAgnieszka K Witkiewicz, Christina L Costantino, Richard Metz, et al.Journal of Immunology (Baltimore, Md. : 1950)|February 26, 2010
Induction of IDO-1 by immunostimulatory DNA limits severity of experimental colitisMatthew A Ciorba, Ellen E Bettonville, Keely G McDonald, et al.Oncoimmunology|December 25, 2012
IDO inhibits a tryptophan sufficiency signal that stimulates mTOR: A novel IDO effector pathway targeted by D-1-methyl-tryptophanRichard Metz, Sonja Rust, James B Duhadaway, et al.Pageof 4